Mild cognitive impairment: risk of dementia according to subtypes

Cecilia M Serrano1, Carol Dillon, Adriana Leis

  • 1Laboratorio De Investigación De La Memoria Hospital Abel Zubizarreta, Buenos Aires Servicio de Investigación y Rehabitación Neurocognitiva-SIREN-CEMIC.

Abstract

Insights

Mild cognitive impairment (MCI) subtypes have varying dementia conversion rates. Amnestic MCI showed the highest conversion to Alzheimer's disease, with age and retirement as key risk factors.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) presents in three subtypes: amnestic (aMCI), multiple domains (mdMCI), and non-amnestic single domain (na-SD-MCI).
  • The long-term evolution and conversion rates to dementia for these MCI subtypes require further investigation.

Purpose of the Study:

  • To determine the conversion rate to dementia across different MCI subtypes.
  • To identify risk factors associated with the progression from MCI to dementia.

Main Methods:

  • A cohort of 127 patients diagnosed with MCI and 17 healthy controls were assessed using comprehensive neuropsychological and neuropsychiatric evaluations.
  • MCI patients were categorized into amnestic MCI (n=20), multiple-domain MCI (n=98), and non-amnestic MCI (n=9) groups.

Main Results:

  • Overall, 27.1% of MCI patients converted to Alzheimer's-type dementia (AD) within an average of 11.12 months.
  • The amnestic MCI subtype exhibited the highest conversion rate to AD (35%), followed by multiple-domain MCI (31.6%) and non-amnestic MCI (11.1%).
  • Advanced age and retirement status were identified as significant risk factors increasing the likelihood of conversion to dementia.

Conclusions:

  • The amnestic MCI subtype demonstrates the highest propensity for conversion to Alzheimer's disease.
  • Age and retirement are critical factors influencing the progression from mild cognitive impairment to dementia.
  • Understanding subtype-specific conversion rates and risk factors is crucial for predicting dementia development and informing clinical management.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
693
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K